{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:50:48Z","timestamp":1781761848365,"version":"3.54.5"},"reference-count":77,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005049","name":"Science and Engineering Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001805","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.xcrm.2024.101755","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T05:07:55Z","timestamp":1728018475000},"page":"101755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases"],"prefix":"10.1016","volume":"5","author":[{"given":"Agata M.","family":"Kieliszek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mobilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blessing I.","family":"Bassey-Archibong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrod W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew L.","family":"Piotrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvin D.","family":"de Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abootaleb","family":"Sedighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoo","family":"Aghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Gwynne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Quaile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillon","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minomi","family":"Subapanditha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Tokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Vaseem Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn C.","family":"Chafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Gunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Rafael","family":"Montenegro-Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Magolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101755_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0305-7372(03)00105-1","article-title":"The management of brain metastases","volume":"29","author":"Patchell","year":"2003","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.xcrm.2024.101755_bib2","series-title":"Brain metastases 10.1038\/s41572-018-0055-y","author":"Soffietti","year":"2011"},{"key":"10.1016\/j.xcrm.2024.101755_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41016-018-0149-0","article-title":"Management of brain metastases: history and the present","volume":"5","author":"Liu","year":"2019","journal-title":"Chin. Neurosurg. J."},{"key":"10.1016\/j.xcrm.2024.101755_bib4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fonc.2017.00230","article-title":"Genetic characterization of brain metastases in the era of targeted therapy","volume":"7","author":"Han","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2024.101755_bib5","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"PK","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101755_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41588-020-0592-7","article-title":"Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma","volume":"52","author":"Shih","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2024.101755_bib7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0002-9440(10)65628-3","article-title":"Multistep Nature of Metastatic Inefficiency: Dormancy of Solitary Cells after Successful Extravasation and Limited Survival of Early Micrometastases","volume":"153","author":"Luzzi","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2024.101755_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.xcrm.2024.101755_bib9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4161\/cc.7.2.5326","article-title":"Cell Cycle Metastatic cancer stem cells: A new target for anti-cancer therapy?","volume":"7","author":"Hermann","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.xcrm.2024.101755_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.201202014","article-title":"The evolving concept of cancer and metastasis stem cells","volume":"198","author":"Baccelli","year":"2012","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.xcrm.2024.101755_bib11","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/gb-2010-11-5-r52","article-title":"Towards a comprehensive structural variation map of an individual human genome","volume":"11","author":"Pang","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2024.101755_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00401-017-1757-z","article-title":"RNAi screen identifies essential regulators of human brain metastasis-initiating cells","volume":"134","author":"Singh","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xcrm.2024.101755_bib13","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/0008-5472.CAN-18-1022","article-title":"Therapeutic Targeting of the Premetastatic Stage in Human Lung-to-Brain Metastasis","volume":"78","author":"Singh","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101755_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2205247120","article-title":"An HLA-G\/SPAG9\/STAT3 axis promotes brain metastases","volume":"120","author":"Bassey-Archibong","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101755_bib15","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.3390\/ijms15059117","article-title":"Brain metastasis-initiating cells: survival of the fittest","volume":"15","author":"Singh","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2024.101755_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/neuonc\/noab267","article-title":"Low and steady wins the race: For melanoma brain metastases, is prevention better than a cure?","volume":"24","author":"Kieliszek","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2024.101755_bib17","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101755_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-4939-8805-1_19","article-title":"Vivo Murine Models of Brain Metastasis","volume":"1869","author":"Singh","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2024.101755_bib19","doi-asserted-by":"crossref","first-page":"13152","DOI":"10.1021\/acs.jmedchem.1c00910","article-title":"Strategies for Structural Modification of Small Molecules to\u00a0Improve Blood\u2013Brain Barrier Penetration: A Recent Perspective","volume":"64","author":"Xiong","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2024.101755_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.xcrm.2024.101755_bib21","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1093\/ndt\/gfn360","article-title":"Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil","volume":"23","author":"Neumann","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.xcrm.2024.101755_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/jnci\/djt022","article-title":"A Cancer Stem Cell Model for Studying Brain Metastases From Primary Lung Cancer","volume":"105","author":"Nolte","year":"2013","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.xcrm.2024.101755_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","article-title":"ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays","volume":"347","author":"Hu","year":"2009","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2024.101755_bib24","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.3390\/biomedicines10112784","article-title":"Wound Healing versus Metastasis: Role of Oxidative Stress","volume":"10","author":"Lopez","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.xcrm.2024.101755_bib25","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: Wounds That Do Not Heal","volume":"315","author":"Flier","year":"1986","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101755_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/onc.2011.212","article-title":"Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer","volume":"31","author":"Kondratyev","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2024.101755_bib27","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1186\/s12885-020-07193-6","article-title":"Antagonists of the serotonin receptor 5A target human breast tumor initiating cells","volume":"20","author":"Gwynne","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2024.101755_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2024.101755_bib29","first-page":"1659","article-title":"Mycophenolic acid morpholinoethyl ester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T-and B-cell purine synthesis","volume":"22","author":"Morris","year":"1990","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.xcrm.2024.101755_bib30","series-title":"Preparation of morpholinoethyl esters of mycophenolic acid and pharmaceutical compositions containing them as immunosuppressive and anti-inflammatory agents","author":"Nelson","year":"1988"},{"key":"10.1016\/j.xcrm.2024.101755_bib31","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(96)10310-X","article-title":"Mycophenolate mofetil","volume":"348","author":"Lipsky","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2024.101755_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127543","article-title":"Mycophenolic anilides as broad specificity inosine-5\u2019-monophosphate dehydrogenase (IMPDH) inhibitors","volume":"30","author":"Lee","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.xcrm.2024.101755_bib33","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1080\/14756366.2018.1474211","article-title":"Newer human inosine 5\u2019-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents","volume":"33","author":"Shah","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.xcrm.2024.101755_bib34","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jps.21580","article-title":"Comparison of blood-brain barrier permeability assays: in\u00a0situ brain perfusion, MDR1-MDCKII and PAMPA-BBB","volume":"98","author":"Kerns","year":"2009","journal-title":"J.\u00a0Pharmaceut. Sci."},{"key":"10.1016\/j.xcrm.2024.101755_bib35","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1021\/acs.jmedchem.1c01585","article-title":"Discovery of HDAC6-Selective Inhibitor NN-390 with in\u00a0Vitro Efficacy in Group 3 Medulloblastoma","volume":"65","author":"Nawar","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2024.101755_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2004.10.007","article-title":"Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier","volume":"288","author":"Wang","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.xcrm.2024.101755_bib37","first-page":"204","article-title":"Functional Expression of P-glycoprotein in Rat Brain Microglia","volume":"299","author":"Lee","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.xcrm.2024.101755_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091346","article-title":"Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story","volume":"11","author":"Naffouje","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2024.101755_bib39","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/op800060h","article-title":"Development and Manufacture of the Inosine Monophosphate Dehydrogenase Inhibitor Merimepodib, VX-497","volume":"12","author":"Looker","year":"2008","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.xcrm.2024.101755_bib40","article-title":"Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance","volume":"2011","author":"Moore","year":"2011","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.xcrm.2024.101755_bib41","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1038\/s41467-020-17512-x","article-title":"Purine metabolism regulates DNA repair and therapy resistance in glioblastoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101755_bib42","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1152\/physrev.00062.2017","article-title":"Brain Glucose Metabolism: Integration of Energetics with Function","volume":"99","author":"Dienel","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.xcrm.2024.101755_bib43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","article-title":"Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nat. cancer"},{"key":"10.1016\/j.xcrm.2024.101755_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12880-021-00602-7","article-title":"Differentiation of brain metastases from small and non-small lung cancers using apparent diffusion coefficient (ADC) maps","volume":"21","author":"M\u00fcller","year":"2021","journal-title":"BMC Med. Imag."},{"key":"10.1016\/j.xcrm.2024.101755_bib45","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2024.101755_bib46","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1038\/s41467-022-33365-y","article-title":"The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101755_bib47","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer Metastasis: Building a Framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101755_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43094-020-00047-9","article-title":"Exploring different approaches to improve the success of drug discovery and development projects: a review","volume":"6","author":"Kiriiri","year":"2020","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.xcrm.2024.101755_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw8412","article-title":"Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials","volume":"11","author":"Lin","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2024.101755_bib50","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101755_bib51","article-title":"Purine metabolism promotes radioresistance and is a therapeutic target in glioblastoma","volume":"7","author":"Zhou","year":"2020","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.xcrm.2024.101755_bib52","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101755_bib53","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/neuonc\/nos117","article-title":"Current clinical development of PI3K pathway inhibitors in glioblastoma","volume":"14","author":"Wen","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2024.101755_bib54","series-title":"Purine Synthesis and Salvage in Brain and Liver","first-page":"21","author":"Allsop","year":"1984"},{"key":"10.1016\/j.xcrm.2024.101755_bib55","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nbt.2530","article-title":"Heterogeneity of tumor-induced gene expression changes in the human metabolic network","volume":"31","author":"Hu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101755_bib56","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.4537","article-title":"Purine synthesis promotes maintenance of brain tumor initiating cells in glioma","volume":"20","author":"Wang","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.xcrm.2024.101755_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173580","article-title":"Therapeutic potential and molecular mechanisms of mycophenolic acid as an anticancer agent","volume":"887","author":"Benjanuwattra","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101755_bib58","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.intimp.2005.01.015","article-title":"Effects of mycophenolic acid on endothelial cells","volume":"5","author":"Huang","year":"2005","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.xcrm.2024.101755_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.xcrm.2024.101755_bib60","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202115631","article-title":"IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia","volume":"15","author":"Liu","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2024.101755_bib61","first-page":"i10","article-title":"DDRE-19. PHASE 0\/I TRIAL OF MYCOPHENOLATE MOFETIL COMBINED WITH RADIATION TO OVERCOME GLIOBLASTOMA TREATMENT RESISTANCE BY TARGETING DE-NOVO PURINE METABOLISM","volume":"3","author":"Umemura","year":"2021","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.xcrm.2024.101755_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101628","article-title":"Derivation and culturing of neural stem cells from human embryonic brain tissue","volume":"3","author":"Suk","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2024.101755_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2017.00220","article-title":"Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System","volume":"7","author":"Singh","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2024.101755_bib64","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-8805-1","article-title":"Brain Tumor Stem Cells: Methods and Protocols","author":"Singh","year":"2019"},{"key":"10.1016\/j.xcrm.2024.101755_bib65","doi-asserted-by":"crossref","first-page":"27461","DOI":"10.18632\/oncotarget.4742","article-title":"STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation","volume":"6","author":"Singh","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2024.101755_bib67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4939-8805-1_16","article-title":"In\u00a0Vitro Assays for Screening Small Molecules","volume":"1869","author":"Adile","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2024.101755_bib68","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1158\/0008-5472.CAN-18-0267","article-title":"Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma","volume":"78","author":"Qazi","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101755_bib69","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1158\/1078-0432.CCR-14-3147","article-title":"Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells","volume":"21","author":"Venugopal","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101755_bib70","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41388-019-1086-x","article-title":"A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells","volume":"39","author":"Manoranjan","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2024.101755_bib71","series-title":"In\u00a0Vitro Self-Renewal Assays for Brain Tumor Stem Cells","first-page":"79","author":"Seyfrid","year":"2019"},{"key":"10.1016\/j.xcrm.2024.101755_bib72","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1021\/jo971176v","article-title":"NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities","volume":"62","author":"Gottlieb","year":"1997","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.xcrm.2024.101755_bib73","series-title":"Brain Tumor Stem Cells","author":"Singh","year":"2019"},{"key":"10.1016\/j.xcrm.2024.101755_bib74","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1021\/jo00408a041","article-title":"Rapid chromatographic technique for preparative separations with moderate resolution","volume":"43","author":"Still","year":"1978","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.xcrm.2024.101755_bib66","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0091-679X(08)60989-9","article-title":"Fluorescence labeling and microscopy of DNA","volume":"30","author":"Arndt-Jovin","year":"1989","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.xcrm.2024.101755_bib75","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.ccell.2022.10.009","article-title":"Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma","volume":"40","author":"Gwynne","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101755_bib76","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1534\/g3.117.041277","article-title":"Evaluation and Design of Genome-Wide CRISPR\/SpCas9 Knockout Screens","volume":"7","author":"Hart","year":"2017","journal-title":"G3 (Bethesda)."},{"key":"10.1016\/j.xcrm.2024.101755_bib77","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","article-title":"High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities","volume":"163","author":"Hart","year":"2015","journal-title":"Cell"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124004853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124004853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T21:53:02Z","timestamp":1731621182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124004853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2666379124004853"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101755","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101755"}}